Single-cell analysis highlights differences in druggable pathways underlying adaptive or fibrotic kidney regeneration
2022 · Nature Communications · 172 citations
https://doi.org/10.1038/s41467-022-31772-9
H
Hailong Hu
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
151
Papers
2.1K
Citations
24
h-index
44
i10-index
Hailong Hu is an academic researcher from Children's Hospital of Philadelphia. The author has contributed to research in topics: Bladder and Urothelial Cancer Treatments & Urinary and Genital Oncology Studies & Ferroptosis and cancer prognosis. The author has an h-index of 24, co-authored 129 publications.
ORCID: 0000-0002-0565-7752Papers by this author
worksIncreased levels of endogenous retroviruses trigger fibroinflammation and play a role in kidney disease development
2023 · Nature Communications · 72 citations
https://doi.org/10.1038/s41467-023-36212-w
Kidney multiome-based genetic scorecard reveals convergent coding and regulatory variants
2025 · Science · 30 citations
https://doi.org/10.1126/science.adp4753
The critical role of endoplasmic reticulum stress and the stimulator of interferon genes (STING) pathway in kidney fibrosis
2024 · Kidney International · 26 citations
https://doi.org/10.1016/j.kint.2024.10.021
Low-dose hexavalent chromium(VI) exposure promotes prostate cancer cell proliferation by activating MAGEB2-AR signal pathway
2022 · Ecotoxicology and Environmental Safety · 14 citations
https://doi.org/10.1016/j.ecoenv.2022.113724
Letter to the Editor: clinical utility of urine DNA for noninvasive detection and minimal residual disease monitoring in urothelial carcinoma
2023 · Molecular Cancer · 11 citations
https://doi.org/10.1186/s12943-023-01729-7
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat